Role of nitrergic and endothelin pathways modulations in cisplatin-induced nephrotoxicity in male rats

Journal of Physiology and Pharmacology

Volumn 65, Issue 3, 2014, Pages 393-399

  Helmy, M W ^a   Helmy, M M ^b   Abd Allah, D M ^c   Abo Zaid, A M ^a   Mohy El Din, M M ^b  

^a PHAROS UNIVERSITY IN ALEXANDRIA   (Egypt)

^b Alexandria University Faculty of Pharmacy   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Blood urea nitrogen; Cisplatin; Endothelin 1; Endothelin a receptor antagonist; Malondialdehyde; Nephrotoxicity; Sildenafil; Superoxide dismutase

Indexed keywords

CASPASE 3; CISPLATIN; CYCLO (DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN RECEPTOR; MALONALDEHYDE; NITRIC OXIDE; SILDENAFIL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; KIDNEY FUNCTION; KIDNEY HOMOGENATE; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NITRERGIC NERVE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; CHEMICALLY INDUCED; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACUTE KIDNEY INJURY; ANIMALS; CISPLATIN; ENDOTHELINS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84902462717     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bennett PN, Brown MJ. Clinical Pharmacology. Churchill Livingstone, 2003, 606.
2. Von-Hoff DD, Schilsky R, Reichert CM, et al. Toxic effects of cis-dichlorodiammine platinum in man. Cancer Treat Rep 1979; 63: 1527-1531.
3. Schrier RW. Cancer therapy and renal injury. J Clin Invest 2002; 110: 743-745.
4. Saleh S, El-Demerdash E. Protective effects of l-arginine against cisplatin induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol 2005; 97: 91-97.
5. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 2005; 68: 2131-2142.
6. Das A, Ockaili R, Salloum F, Kukreja RC. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am J Physiol Heart Circ Physiol 2004; 286: H1455-H1460.
7. Lee KW, Jeong J Y, Lim BJ, et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009; 257: 137-143.
8. Takaoka M, Kuro T, Matsumura Y. Role of endothelin in the pathogenesis of acute renal failure. Drug News Perspect 2000; 13: 141-146.
9. Kone BC. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health. Semin Nephrol 2004; 24: 299-315.
10. Slowinski T, Subkowski T, Diehr P, et al. Interaction of the endothelin system and calcineurin inhibitors after kidney transplantation. Clin Sci (Lond) 2002; 103 (Suppl. 48): 396S-398S.
11. Lee S, Ahn D. Expression of endothelin-1 and its receptors in cisplatin-induced acute renal failure in mice. Korean J Physiol Pharmacol 2008; 12: 149-153.
12. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 1980; 213: 551-556.
13. Garrido MR, Israel A. Role of endothelin in stress-induced hypertension. J Hum Hypertens 2002; 16 (Suppl. 1): S29-S33.
14. Borch RF, Pleasants ME. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc Natl Acad Sci USA 1979; 76: 6611-6614.
15. Ottolenghi A. 2-Thiobarbituric acid (TBA) method. Arch Biochem Biophys 1959; 77: 355-360.
16. Marklund S, Marklund G. Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for SOD. Eur J Biochem 1974; 47: 469-474.
17. Guevara I, Iwanejko J, Dembinska-Kiec A, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998; 274: 177-188.
18. Carleton HM. Carleton's Histological Techniques. Oxford Medical Publications, Oxford University Press, 1980; pp. 58-68, 90-95, 132-150, 182-198.
19. Tagboto S, Griffiths A P. The evaluation of renal ischaemic damage: the value of CD10 monoclonal antibody staining and of biochemical assessments of tissue viability. BMC Clin Pathol 2007; 7: 5.
20. McWhinnie DL, Thompson JF, Taylor HM, et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 1986; 42: 352-358.
21. Chatterjee PK, Cuzzocrea S, Brown PA, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000; 58: 658-673.
22. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34: 1522-1534.
23. Daugaard G, Abildgaard U. Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol 1989; 25: 1-9.
24. Reiter RJ, Tan DX, Korkmaz A, Fuentes-Broto L. Drug-mediated ototoxicity and tinnitus: alleviation with melatonin. J Physiol Pharmacol 2011; 62: 151-157.
25. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol 2004; 18: 37-52.
26. Kang D G, Lee AS, Mun YJ, et al. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 2004; 27: 366-370.
27. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417-430.
28. Antunes LM, Darin JD, Bianchi N de L. Effects of antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 2001; 43: 145-150.
29. Mora LO, Antunes LM, Francescato HD, Bianchi M. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003; 47: 517-522.
30. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 1997; 23: 209-240.
31. Kuhlmann MK, Burkhardt G, Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-2480.
32. Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. Inhibition of nitric oxide synthase aggravates cisplatin induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 2002; 48: 309-315.
33. Offerman JJ, Meijer S, Sleijfer DT, et al. Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. Cancer Chemother Pharmacol 1984; 12: 36-38.
34. Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007; 230: 64-75.
35. Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 2007; 230: 256-264.
36. Kiymaz N, Yilmaz N, Mumcu C, Anlar O, Ozen S, Kayaoglu CR. Protective effect of sildenafil (Viagra) in transient spinal cord ischemia. Pediatr Neurosurg 2008; 44: 22-28.
37. Merline R, Lazaroski S, Babelova A, et al. Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol 2009; 60 (Suppl. 4): 5-13.
38. Tsuruya K, Ninomiya T, Tokumoto M, et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003; 63: 72-82.
39. Lau AH. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int 1999; 56: 1295-1298.
40. Wilhelm SM, Stowe NT, Robinson AV, Schulak JA. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation 2001; 71: 211-216.
41. Buyukgebiz O, Aktan AO, Haklar G, et al. BQ-123, a specific endothelin (ETA) receptor antagonist prevents ischemia-reperfusion injury in kidney transplantation. Transpl Int 1996; 9: 201-207.
42. Helmy MM, Helmy MW, Abd Allah DM, Abo Zaid AM, Mohy El-Din MM. Selective ETAreceptor blockade protects against cisplatin-induced acute renal failure in male rats. Eur J Pharmacol 2014; 730C: 133-139.